Moderna (MRNA) Announces FDA Requires Additional Time to Decide on Emergency Use Authorization of COVID-19 Vaccine for Adolescents

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. META
3. TSLA
4. STZ
5. GOOGL
6. FDS
7. FUTU
8. HOOD
9. TTE
10. OUST

Go back to Moderna (MRNA) Announces FDA Requires Additional Time to Decide on Emergency Use Authorization of COVID-19 Vaccine for Adolescents

U.S. FDA authorizes first COVID-19 shot for young kids

October 29, 2021 12:46 PM EDT

By Manas Mishra and Michael Erman

(Reuters) -The U.S. Food and Drug Administration on Friday authorized the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years, making it the first COVID-19 shot for young children in the United States.

The shot will not be immediately available to the age group. The U.S. Centers for Disease Control and Prevention still needs to advise on how the shot should be administered, which will be decided after a group of outside advisers discuss the plan on Tuesday.

Pfizer said it will begin shipping... More

Moderna (MRNA) Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries

October 29, 2021 10:15 AM EDT

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement... More